- Home
- HBAN vs BNTX Comparison
HBAN vs BNTX Comparison
Compare HBAN & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBAN
- BNTX
- Stock Information
- Founded
- HBAN 1866
- BNTX 2008
- Country
- HBAN United States
- BNTX Germany
- Employees
- HBAN N/A
- BNTX N/A
- Industry
- HBAN Major Banks
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HBAN Finance
- BNTX Health Care
- Exchange
- HBAN Nasdaq
- BNTX Nasdaq
- Market Cap
- HBAN 25.6B
- BNTX 23.9B
- IPO Year
- HBAN N/A
- BNTX 2019
- Fundamental
- Price
- HBAN $17.17
- BNTX $120.69
- Analyst Decision
- HBAN Buy
- BNTX Strong Buy
- Analyst Count
- HBAN 18
- BNTX 15
- Target Price
- HBAN $17.36
- BNTX $143.50
- AVG Volume (30 Days)
- HBAN 12.4M
- BNTX 1.0M
- Earning Date
- HBAN 01-17-2025
- BNTX 11-04-2024
- Dividend Yield
- HBAN 3.59%
- BNTX N/A
- EPS Growth
- HBAN N/A
- BNTX N/A
- EPS
- HBAN 1.03
- BNTX N/A
- Revenue
- HBAN $6,690,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- HBAN N/A
- BNTX N/A
- Revenue Next Year
- HBAN $5.31
- BNTX N/A
- P/E Ratio
- HBAN $16.67
- BNTX N/A
- Revenue Growth
- HBAN N/A
- BNTX N/A
- 52 Week Low
- HBAN $12.02
- BNTX $76.53
- 52 Week High
- HBAN $18.45
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- HBAN 48.06
- BNTX 57.89
- Support Level
- HBAN $17.18
- BNTX $116.73
- Resistance Level
- HBAN $17.52
- BNTX $123.29
- Average True Range (ATR)
- HBAN 0.32
- BNTX 4.70
- MACD
- HBAN -0.16
- BNTX 0.54
- Stochastic Oscillator
- HBAN 0.00
- BNTX 73.82
About HBAN Huntington Bancshares Incorporated
Huntington is a regional us bank with around $200 billion in assets (as of September 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.